Heterogeneity of Specific Gas Volume Changes: A New Tool to Plan Lung Volume Reduction in COPD

Chest

Volumn 146, Issue 6, 2014, Pages 1554-1565

  Salito, Caterina ^a   Barazzetti, Livia ^a   Woods, Jason C ^b,c   Aliverti, Andrea ^a  

^a POLITECNICO DI MILANO   (Italy)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG EMPHYSEMA; LUNG LOBE; LUNG RESECTION; LUNG VENTILATION; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RESIDUAL VOLUME; TOTAL LUNG CAPACITY; TREATMENT PLANNING; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; LUNG VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATISTICAL MODEL; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; LINEAR MODELS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PNEUMONECTOMY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESIDUAL VOLUME; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

EID: 84964699048     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2855     Document Type: Article

References (21)

1. 1 Lutey, BA, Lefrak, SS, Woods, JC, et al. Hyperpolarized 3He MR imaging: physiologic monitoring observations and safety considerations in 100 consecutive subjects. Radiology 248:2 (2008), 655–661.
2. 2 Woods, JC, Choong, CK, Yablonskiy, DA, et al. Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med 56:6 (2006), 1293–1300.
3. 3 Yablonskiy, DA, Sukstanskii, AL, Woods, JC, et al. Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol (1985) 107:4 (2009), 1258–1265.
4. 4 Mata, JF, Altes, TA, Cai, J, et al. Evaluation of emphysema severity and progression in a rabbit model: comparison of hyperpolarized 3He and 129Xe diffusion MRI with lung morphometry. J Appl Physiol (1985) 102:3 (2007), 1273–1280.
5. 5 Coxson, HO, Rogers, RM, Whittall, KP, et al. A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med 159:3 (1999), 851–856.
6. 6 Coxson, HO, Mayo, JR, Behzad, H, et al. Measurement of lung expansion with computed tomography and comparison with quantitative histology. J Appl Physiol (1985) 79:5 (1995), 1525–1530.
7. 7 Salito, C, Woods, JC, Aliverti, A, Influence of CT reconstruction settings on extremely low attenuation values for specific gas volume calculation in severe emphysema. Acad Radiol 18:10 (2011), 1277–1284.
8. 8 Salito, C, Aliverti, A, Gierada, DS, et al. Quantification of trapped gas with CT and 3 He MR imaging in a porcine model of isolated airway obstruction. Radiology 253:2 (2009), 380–389.
9. 9 Shah, PL, Slebos, DJ, Cardoso, PF, et al. EASE trial study group. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 378:9795 (2011), 997–1005.
10. 10 Venuta, F, Rendina, EA, Coloni, GF, Endobronchial treatment of emphysema with one-way valves. Thorac Surg Clin 19:2 (2009), 255–260.
11. 11 Valipour, A, Herth, FJ, Burghuber, OC, et al. VENT Study Group. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J 43:2 (2014), 387–396.
12. 12 Argula, RG, Strange, C, Ramakrishnan, V, Goldin, J, Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest 144:5 (2013), 1578–1586.
13. 13 Aliverti, A, Pennati, F, Salito, C, Woods, JC, Regional lung function and heterogeneity of specific gas volume in healthy and emphysematous subjects. Eur Respir J 41:5 (2013), 1179–1188.
14. 14 Broncus Technologies. EASE trial: exhale airway stents for emphysema. NCT00391612. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT00391612., 2006 Bethesda, MD: National Institutes of Health; Updated January 2011.
15. 15 Hu, S, Hoffman, EA, Reinhardt, JM, Automatic lung segmentation for accurate quantitation of volumetric X-ray CT images. IEEE Trans Med Imaging 20:6 (2001), 490–498.
16. 16 Kiraly, AP, Higgins, WE, McLennan, G, Hoffman, EA, Reinhardt, JM, Three-dimensional human airway segmentation methods for clinical virtual bronchoscopy. Acad Radiol 9:10 (2002), 1153–1168.
17. 17 Salito, C, Barazzetti, L, Woods, JC, Aliverti, A, 3D airway tree reconstruction in healthy subjects and emphysema. Lung 189:4 (2011), 287–293.
18. 18 Rosenblum, LJ, Mauceri, RA, Wellenstein, DE, et al. Density patterns in the normal lung as determined by computed tomography. Radiology 137:2 (1980), 409–416.
19. 19 Schroeder, JD, McKenzie, AS, Zach, JA, et al. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol 201:3 (2013), W460–470.
20. 20 Hogg, JC, Macklem, PT, Thurlbeck, WM, The resistance of collateral channels in excised human lungs. J Clin Invest 48:3 (1969), 421–431.
21. 21 Macklem, PT, Airway obstruction and collateral ventilation. Physiol Rev 51:2 (1971), 368–436.